China News Service, August 23. According to foreign media reports, on the 23rd local time, the U.S. Food and Drug Administration (FDA) approved the full use authorization of Pfizer's new crown vaccine. When the spread of the delta variant strain caused the U.S. epidemic to rebound, This will help increase people's confidence in vaccination.
Data map: On April 23, local time, the American Museum of Natural History in New York opened the Milstein Marine Biology Hall as a new crown vaccination site to vaccinate New York residents over 18 years old.
Photo by China News Agency reporter Liao Pan
FDA Acting Commissioner Janet Woodcock said: “The public can be very confident that this vaccine meets the high standards of approved products required by the FDA in terms of safety, effectiveness, and production quality.” “Today’s milestones set us away from change. The progress of the U.S. epidemic is one step closer."
Pfizer said that the United States became the first country to fully approve the vaccine.
The company’s CEO Albert Bora said in a statement that he hopes this decision “will help increase people’s confidence in vaccines, because vaccines are still our best tool to help protect lives.”
The number of vaccines in the United States fell to the bottom in July.
As the epidemic rebounded and the number of hospitalizations increased, the number of vaccinated people rose again-1 million vaccinations a day from August 12th to 14th.
More than half of Americans have been fully vaccinated.